CRYOPORT, INC. Retained Earnings
CRYOPORT, INC. (CYRX) had Retained Earnings of -$707.68 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$707.68M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$699.43M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$688.88M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$675.24M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$707.68M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$699.43M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | -$688.88M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$675.24M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$668.24M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | -$769.16M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$757.17M 10-K · filed 2026-03-05 | |
| 2024-09-30 | -$738.50M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$739.30M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$661.31M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -$642.42M 10-K · filed 2025-03-07 | |
| 2023-09-30 | -$580.03M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$566.76M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$548.41M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | -$542.83M 10-K · filed 2024-03-13 | |
| 2022-09-30 | -$503.79M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | -$498.47M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$489.29M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | -$467.54M 10-K · filed 2023-02-28 | |
| 2021-09-30 | -$207.46M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$200.93M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | -$195.54M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$192.01M 10-K · filed 2022-02-28 | |
| 2020-09-30 | -$180.48M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | -$169.07M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | -$163.26M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | -$159.32M 10-K · filed 2021-03-01 | -$159.32M 10-K · filed 2020-03-10 |
| 2019-09-30 | -$158.37M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$145.90M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$143.38M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$140.99M 10-K · filed 2020-03-10 | |
| 2018-09-30 | -$138.73M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$136.59M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$134.12M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | -$131.43M 10-K · filed 2019-03-13 | |
| 2017-09-30 | -$129.16M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | -$127.18M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$125.32M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | -$123.53M 10-K · filed 2018-03-08 | |
| 2016-09-30 | -$119.25M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$117.07M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$113.13M 10-KT · filed 2017-03-13 | |
| 2015-12-31 | -$109.35M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | -$106.59M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$104.17M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$97.77M 10-K · filed 2016-06-28 | |
| 2014-12-31 | -$93.93M 10-Q · filed 2015-02-05 | |
| 2014-09-30 | -$92.03M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | -$88.92M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | -$85.88M 10-K · filed 2015-05-19 | |
| 2013-12-31 | -$84.43M 10-Q · filed 2014-02-13 | |
| 2013-09-30 | -$82.59M 10-Q · filed 2013-11-18 | |
| 2013-06-30 | -$67.63M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$66.31M 10-K · filed 2014-06-25 | |
| 2012-12-31 | -$64.59M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | -$63.03M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | -$61.47M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$59.93M 10-K · filed 2013-06-25 | |
| 2011-12-31 | -$58.26M 10-Q · filed 2012-02-21 | |
| 2011-09-30 | -$56.18M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$54.15M 10-Q · filed 2011-08-15 | |
| 2011-03-31 | -$52.10M 10-K · filed 2012-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |